JENNIFER JOY: Open Payments
NPI 1811210552 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 69 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $1,453
Food & beverage: $1,353Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $195 |
| Incyte Corporation | 5 | $179 |
| Janssen Biotech, Inc. | 10 | $150 |
| Novartis Pharmaceuticals Corporation | 8 | $148 |
| Celgene Corporation | 6 | $104 |
| Eisai Inc. | 5 | $84 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Stemline Therapeutics Inc. | 3 | $62 |
| GENZYME CORPORATION | 3 | $59 |
| JAZZ PHARMACEUTICALS INC. | 2 | $52 |
Products named: KISQALI, DATROWAY, REBLOZYL, Enhertu, Lenvima, JAKAFI, OJJAARA, ERLEADA.
Industry payments across MO — which companies pay providers there.
